Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v8-FR | Version v6-FR | |
---|---|---|
Language | French | French |
Date Updated | 2018-08-22 | 2018-08-10 |
Drug Identification Number | 02459906 | 02459906 |
Brand name | ACETYLCYSTEINE SOLUTION USP | ACETYLCYSTEINE SOLUTION USP |
Common or Proper name | Acetylcysteine Solution USP | Acetylcysteine Solution USP |
Company Name | HIKMA CANADA LIMITED | HIKMA CANADA LIMITED |
Ingredients | ACETYLCYSTEINE | ACETYLCYSTEINE |
Strength(s) | 200MG | 200MG |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | INHALATION INTRAVENOUS ORAL | INHALATION INTRAVENOUS ORAL |
Packaging size | 10 mL | 10 mL |
ATC code | R05CB | R05CB |
ATC description | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. | EXPECTORANTS,EXCL COMBINATIONS WITH COUGH SUPPR. |
Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
Anticipated start date | ||
Actual start date | 2018-02-12 | 2018-02-12 |
Estimated end date | 2018-08-29 | 2018-08-15 |
Actual end date | ||
Shortage status | Actual shortage | Actual shortage |
Tier 3 Status | No | No |
Company comments | Alveda DIN 02300435 Acetylcysteine Injection 200 mg/mL is discontinued. Product will be available as Teligent DIN 02459906 Acetylcysteine Solution USP will be in stock July 22 2018. | Alveda DIN 02300435 Acetylcysteine Injection 200 mg/mL is discontinued. Product will be available as Teligent DIN 02459906 Acetylcysteine Solution USP will be in stock July 22 2018. |
Health Canada comments |